Dr. Kathleen Moore, M.D., MS
Claim this profileUniversity of Oklahoma Health Sciences Center
Expert in Ovarian Cancer
Expert in Ovarian Tumors
29 reported clinical trials
81 drugs studied
About Kathleen Moore, M.D., MS
Education:
- Earned an MD from the University of Oklahoma College of Medicine in 1995.
- Obtained an MS in Clinical Research from the University of Oklahoma Health Sciences Center in 2007.
Experience:
- Director of the Gynecologic Oncology Fellowship Program at Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
- Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma Health Sciences Center.
- Renowned gynecologic oncologist and clinical researcher, specializing in ovarian cancer and other gynecologic malignancies.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
KRAS positive
BRCA positive
2Ovarian Tumors
Global LeaderStage IV
BRCA1 positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Kathleen Moore, M.D., MS is currently running
SHetA2
for Gynecologic Cancers
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
Recruiting1 award Phase 1
ADP-A2M4CD8 + Nivolumab
for Ovarian Cancer
This trial tests a treatment using modified immune cells alone or with an immune-boosting drug in patients with recurrent ovarian cancer who have a specific genetic marker. The treatment aims to help the immune system better identify and destroy cancer cells.
Recruiting1 award Phase 221 criteria
More about Kathleen Moore, M.D., MS
Clinical Trial Related1 year of experience running clinical trials · Led 29 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Kathleen Moore, M.D., MS has experience with
- Paclitaxel
- Carboplatin
- Binimetinib
- Olaparib
- Niraparib
- Defactinib
Breakdown of trials Kathleen Moore, M.D., MS has run
Ovarian Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen Moore, M.D., MS specialize in?
Kathleen Moore, M.D., MS focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Kathleen Moore, M.D., MS currently recruiting for clinical trials?
Yes, Kathleen Moore, M.D., MS is currently recruiting for 10 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Kathleen Moore, M.D., MS has studied deeply?
Yes, Kathleen Moore, M.D., MS has studied treatments such as Paclitaxel, Carboplatin, Binimetinib.
What is the best way to schedule an appointment with Kathleen Moore, M.D., MS?
Apply for one of the trials that Kathleen Moore, M.D., MS is conducting.
What is the office address of Kathleen Moore, M.D., MS?
The office of Kathleen Moore, M.D., MS is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.